18-66505195-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_021153.4(CDH19):c.1936G>A(p.Gly646Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000374 in 1,613,076 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00040 ( 7 hom. )
Consequence
CDH19
NM_021153.4 missense
NM_021153.4 missense
Scores
3
7
9
Clinical Significance
Conservation
PhyloP100: 4.59
Genes affected
CDH19 (HGNC:1758): (cadherin 19) This gene is one of three related type II cadherin genes situated in a cluster on chromosome 18. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein containing five extracellular cadherin repeats. Loss of cadherins may be associated with cancer formation. Alternative splicing results in multiple transcript variants for this gene. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.015978396).
BP6
Variant 18-66505195-C-T is Benign according to our data. Variant chr18-66505195-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3037960.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH19 | NM_021153.4 | c.1936G>A | p.Gly646Ser | missense_variant | 12/12 | ENST00000262150.7 | NP_066976.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH19 | ENST00000262150.7 | c.1936G>A | p.Gly646Ser | missense_variant | 12/12 | 1 | NM_021153.4 | ENSP00000262150.2 | ||
CDH19 | ENST00000579658.5 | n.*282G>A | non_coding_transcript_exon_variant | 12/12 | 1 | ENSP00000463085.1 | ||||
CDH19 | ENST00000579658.5 | n.*282G>A | 3_prime_UTR_variant | 12/12 | 1 | ENSP00000463085.1 | ||||
CDH19 | ENST00000540086 | c.*93G>A | 3_prime_UTR_variant | 10/10 | 2 | ENSP00000439593.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151998Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
17
AN:
151998
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000722 AC: 181AN: 250660Hom.: 3 AF XY: 0.000944 AC XY: 128AN XY: 135528
GnomAD3 exomes
AF:
AC:
181
AN:
250660
Hom.:
AF XY:
AC XY:
128
AN XY:
135528
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000402 AC: 587AN: 1460960Hom.: 7 Cov.: 31 AF XY: 0.000583 AC XY: 424AN XY: 726842
GnomAD4 exome
AF:
AC:
587
AN:
1460960
Hom.:
Cov.:
31
AF XY:
AC XY:
424
AN XY:
726842
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 152116Hom.: 0 Cov.: 31 AF XY: 0.000134 AC XY: 10AN XY: 74354
GnomAD4 genome
AF:
AC:
17
AN:
152116
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
105
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CDH19-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 15, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of glycosylation at G646 (P = 0.0012);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at